SEMINARS IN RADIATION ONCOLOGY is a premier journal published by W B SAUNDERS CO-ELSEVIER INC, dedicated to advancing the field of radiation oncology through high-quality research and comprehensive reviews. With an impressive impact factor and a notable HIndex, this journal holds a prominent place within the academic community, particularly illustrated by its Q2 ranking in both Cancer Research and Oncology, and a Q1 ranking in Radiology, Nuclear Medicine, and Imaging as of 2023. Since its inception in 1991, the journal has served as a vital resource for researchers, clinicians, and healthcare professionals, facilitating the exchange of innovative ideas and practices that shape the future of cancer treatment. While the journal is not open access, it offers essential insights into the latest advancements in the field, catering to a diverse audience eager to expand their knowledge and improve patient outcomes in the realm of radiation therapy.

Translational Oncology is a premier open access journal published by Elsevier Science Inc, dedicated to the rapidly evolving field of cancer research and oncology. Since its inception in 2008, the journal has been a vital platform for the dissemination of innovative research and findings that bridge the gap between laboratory discoveries and clinical applications. With an impressive impact factor and ranked Q2 in Cancer Research and Q1 in Oncology, it occupies a prominent position in the academic landscape, helping to shape the future of cancer therapeutics and patient care. The journal offers valuable insights across a diverse array of topics, including molecular biology, genetic factors in cancer, and innovative treatment strategies, ensuring relevance and engagement for its readership. As it converges toward 2024, Translational Oncology continues to attract a global audience of researchers, healthcare professionals, and students committed to advancing our understanding of cancer and enhancing clinical outcomes.

Surgical Oncology Clinics of North America, published by W B Saunders Co-Elsevier Inc, is a leading journal in the fields of surgical oncology and surgery, captivating readers since its inception in 1995. With ISSN 1055-3207 and E-ISSN 1558-5042, this esteemed journal offers a comprehensive platform for the dissemination of cutting-edge research, clinical studies, and expert reviews pertaining to surgical techniques and oncological advancements. The journal currently holds a commendable Q3 ranking in Oncology and a Q2 ranking in Surgery, underpinned by its impressive Scopus rankings that place it in the top 25% of its category in Medicine, particularly in the surgical domain (Rank #137/551). Although it does not operate under an open-access model, the insights shared within its pages are invaluable for researchers, healthcare professionals, and students dedicated to enhancing patient outcomes in surgical oncology. With a commitment to advancing medical knowledge, Surgical Oncology Clinics of North America remains a crucial resource for those pursuing excellence in surgical practices and oncology treatment methodologies.

JCO Precision Oncology, published by Lippincott Williams & Wilkins, is a leading journal in the field of cancer research and oncology, recognized for its high-impact contributions and innovative approaches to precision medicine. Since its inception in 2017, this journal has consistently ranked in the Q1 category in both Cancer Research and Oncology for 2023, reflecting its esteemed position within the academic community. With a rigorous peer-review process and a focus on disseminating cutting-edge research, JCO Precision Oncology serves as a vital platform for researchers, clinicians, and healthcare professionals aiming to enhance the understanding and treatment of cancer through individualized therapies. The journal's comprehensive scope includes studies on genetic profiling, biomarker research, and novel therapeutic strategies, making it an essential resource for anyone involved in cancer care and research. Explore further and join a community committed to advancing precision oncology and improving patient outcomes.

World Journal of Clinical Oncology, published by BAISHIDENG PUBLISHING GROUP INC, stands as a vital resource in the realm of oncology, providing a dedicated platform for the dissemination of cutting-edge research and clinical advancements. With an ISSN of 2218-4333, this journal facilitates a comprehensive exploration of modern oncology challenges and breakthroughs, targeting researchers, healthcare professionals, and students alike. Although it operates under the traditional subscription model, the impactful nature of its content is reflected in its notable ranking of 60 out of 334 in the category of Medicine _ Oncology, placing it in the 82nd percentile among peer publications. Covering significant topics in clinical oncology from 2014 to 2018, the journal has been instrumental in addressing evolving oncology practices and patient care innovations. By publishing high-quality studies, it remains an essential tool for advancing knowledge and fostering collaboration within the global oncology community.

Oral and Maxillofacial Surgery-Heidelberg, published by Springer Heidelberg, stands as a pivotal resource in the fields of oral surgery, otorhinolaryngology, and general surgery. With an ISSN of 1865-1550 and E-ISSN 1865-1569, this peer-reviewed journal has been contributing significant scholarly content since its inception in 2003, with a focus on advancing knowledge and practices through innovative research studies, clinical techniques, and reviews. As a recognized Q2 journal across multiple categories—including Oral Surgery, Otorhinolaryngology, and Surgery—it ranks prominently in Scopus rankings, reflecting its impact and relevance within the medical and dental communities. Despite its non-Open Access model, the journal remains important for researchers and professionals seeking cutting-edge insights and developments in maxillofacial surgery. With a commitment to enhancing clinical practices and patient outcomes, Oral and Maxillofacial Surgery-Heidelberg is an essential resource for those dedicated to advancing the field.

The JOURNAL OF SURGICAL ONCOLOGY, published by Wiley, stands as a pivotal resource for medical professionals, researchers, and students engaged in the fields of surgery and oncology. Established in 1969, this esteemed journal covers a diverse range of topics related to the surgical management of cancer, supporting advancements in treatment protocols and patient care. With a Q1 ranking in Surgery and Q2 rankings in both Medicine and Oncology for 2023, it holds a prominent position in the academic landscape, underscoring its impact in enhancing surgical techniques and oncological research. Researchers looking to disseminate their findings will benefit from the journal's rigorous peer-review process and commitment to publishing high-quality content that drives innovation in the field. For access, readers will find both print and online formats available, making vital research accessible to a broad audience committed to improving surgical oncology practice.

The Archives of Oral Biology, published by Pergamon-Elsevier Science Ltd, is a prestigious journal that has been at the forefront of oral biology research since its inception in 1959. With a focus on advancing knowledge in the fields of cell biology, dentistry, and otorhinolaryngology, this journal serves as a critical platform for disseminating innovative research findings, spanning from fundamental scientific studies to clinical applications. The journal enjoys a respectable impact factor, with notable rankings in various categories, including Q2 in Dentistry and Otorhinolaryngology, making it highly relevant for professionals and researchers alike. Though not open access, the Archives of Oral Biology continues to attract high-quality submissions and remains an influential source of information for the global scientific community, contributing significantly to the understanding of oral health and disease.

The British Journal of Cancer, published by SpringerNature, stands as a preeminent resource in the fields of Cancer Research and Oncology, with a distinguished history of publication dating back to 1947. With its Q1 rank in both categories for 2023, this journal is among the top-tier publications, offering cutting-edge research and insights into the biology, etiology, and treatment of cancer. The journal’s rigorous peer-review process ensures that readers are presented with high-quality studies that contribute to the advancement of cancer knowledge and clinical practice. Operating from the United Kingdom, it has garnered a notable impact factor and ranks impressively within Scopus, making it an essential publication for researchers, healthcare professionals, and students who are dedicated to understanding cancer's complexities. Access to the journal's articles is available in traditional formats, providing a versatile platform for disseminating pivotal research. As we move towards a future where cancer treatment and prevention remain crucial, the British Journal of Cancer continues to play a vital role in shaping the dialogue and discoveries within the oncology community.

CLINICAL OTOLARYNGOLOGY is a prestigious peer-reviewed journal published by Wiley that focuses on advancing research in the field of otorhinolaryngology, including topics such as laryngeal surgery, sinus diseases, and head and neck oncology. With an ISSN of 1749-4478 and an E-ISSN of 1749-4486, this journal has established itself as a vital resource for healthcare professionals, researchers, and students interested in ear, nose, and throat (ENT) medicine. The journal is recognized for its rigorous standards, exemplified by its Q2 ranking in both the Medicine (Miscellaneous) and Otorhinolaryngology categories, as per the 2023 Scopus ranking, placing it within the 71st percentile among global journals in its field. Operating from its UK base in Hoboken, NJ, CLINICAL OTOLARYNGOLOGY also contributes to the scientific community's understanding of this specialized area of medicine, with a publication timeline spanning from 2005 to 2024. While it does not offer an open-access model, the journal's quality and impact make it a crucial platform for disseminating high-caliber research that informs clinical practices and fosters innovation in otolaryngology.